19:20 , Oct 11, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Melanoma Patient sample and mouse studies suggest HAPLN1 could help treat metastatic melanoma. In 192 non-metastatic melanoma patients, high regional lymphatic tissue expression of HAPLN1 correlated with survival. In a mouse model of metastatic...
07:00 , Sep 19, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Pain Hyaluronan and proteoglycan link protein 1 (HAPLN1; LPP) In vitro studies suggest LPP could help treat intervertebral disc degeneration-associated chronic lower back pain. Treatment...
07:00 , Mar 27, 2008 |  BC Innovations  |  Targets & Mechanisms

Celiac Attack

The only current treatment for celiac disease, a disorder of the small intestine that results from a hypersensitivity to ingested gluten, is lifelong adherence to a gluten-free diet. However, it is difficult to follow such...
07:00 , Sep 3, 2002 |  BC Week In Review  |  Company News

Alkermes other research news

Researchers published in the Proceedings of the National Academy of Sciences that large porous carriers of nanoparticles retain better flow and aerosolization properties of advantage large porous particle (LPP) systems, while also adding the sustained...